Cigna Corporation CI Income Statement

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18
Revenues
Premiums
40,583	39,714	38,817	37,876	37,085	36,113	0	0	0
Net investment income
1,397	1,390	1,479	1,485	1,497	1,480	0	0	0
Total revenues
154,089	153,566	129,621	102,522	75,183	48,650	0	0	0
Benefits and expenses
Pharmacy and other service costs
97,808	97,668	76,582	52,632	28,282	4,793	0	0	0
Medical costs and other benefit expenses
31,521	30,819	30,038	29,107	28,376	27,528	0	0	0
Selling, general and administrative expenses
14,148	14,053	13,576	13,035	12,492	11,934	0	0	0
Amortization of acquired intangible assets
2,704	2,949	2,350	1,664	951	235	0	0	0
Total benefits and expenses
146,181	145,489	122,546	96,438	70,101	44,490	0	0	0
Income from operations
7,908	8,077	7,075	6,084	5,082	4,160	0	0	0
Interest expense and other
-1,621	-1,682	-1,577	-1,265	-893	-498	0	0	0
Debt extinguishment costs
0	-	-	-	0	-	-	-	-
Net realized investment gains (losses)
79	177	39	-12	-38	-81	0	0	0
Income before income taxes
6,179	6,570	5,537	4,807	4,151	3,581	0	0	0
Total income taxes
1,242	1,450	1,254	1,104	1,050	935	0	0	0
Net income
4,937	5,120	4,283	3,703	3,101	2,646	0	0	0
Less: net income attributable to noncontrolling interests
20	16	12	11	11	9	0	0	0
Shareholders’ net income
4,917	5,104	4,271	3,692	3,090	2,637	0	0	0
Shareholders’ net income per share
Basic (in dollars per share)
3.19	2.64	3.60	3.73	3.61	0.41	3.18	3.32	3.78
Diluted (in dollars per share)
3.15	2.61	3.57	3.70	3.56	0.39	3.14	3.29	3.72
Pharmacy revenues
Revenues
103,018	103,099	80,711	55,471	29,941	5,479	0	0	0
Fees and other revenues
Revenues
9,091	9,363	8,614	7,690	6,660	5,578	0	0	0